Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, January 28, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

AFTER MARKET UPDATE - TUESDAY, FEBRUARY 1ST, 2022
Previous After Market Report Next After Market Report >>>
Indices NYSE Nasdaq
DOW  +273.38 35,405.24 +0.78% Volume 1,010,078,374 -28% Volume 4,577,688,700 -10%
NASDAQ +106.12 14,346.00 +0.75% Advancers 2,433 73% Advancers 3,338 73%
S&P 500 +30.80 4,546.35 +0.68% Decliners 892 27% Decliners 1,207 27%
Russell 2000 +22.29 2,050.74 +1.10% 52 Wk Highs 63   52 Wk Highs 57  
S&P 600 +9.80 1,309.03 +0.75% 52 Wk Lows 48   52 Wk Lows 123  

TODAY'S SPECIAL NOTICE

Disciplined investors will note Monday's follow-through day in the market (M criteria) confirmed a new uptrend. New buying efforts may be made in stocks fitting all key criteria of the fact-based investment system.


Major Averages Posted Gains With Lighter Volume Totals

The S&P 500 climbed 0.7%, while the Nasdaq Composite jumped 0.8% as the two benchmarks aimed to recover from their biggest monthly drawdowns since March 2020. The S&P 500 advanced for a third consecutive session for the first time this year, with its three-day rally the strongest since the depths of the pandemic (+5%). The Dow gained 273 points, back within 3.8% of its January 4 record. Volume totals reported were lighter than the prior session on the NYSE and on the Nasdaq exchange, indicative of less buying demand coming from the institutional crowd. Advancers led decliners by almost a 3-1 margin on the NYSE and on the Nasdaq exchange. There were 14 high-ranked companies from the Leaders List that hit new 52-week highs and were listed on the BreakOuts Page, versus 11 on the prior session. New 52-week highs outnumbered new lows on the NYSE but new lows still outnumbered new highs on the Nasdaq exchangeSolid gains noted on Monday for the Nasdaq Composite (+3.4%) and S&P 500 Index (+1.9%) with higher volume coupled with greater leadership marked a follow-through day confirming a new uptrend for the market averages (M criteria).
Chart courtesy of www.stockcharts.com

PICTURED: The Dow Jones Industrial Average quietly rose above its 200-day moving average (DMA) line toward its 50 DMA line with lighter volume behind the latest gains.

U.S. stocks finished higher on Tuesday as investors digested economic data and corporate earnings. On the data front, an update from the Institute for Supply Management showed U.S. manufacturing activity expanded at the slowest pace since November 2020 last month, while a component measuring input costs spiked. Separately, the Jobs Openings and Labor Turnover Survey (JOLTS) revealed the number of available positions unexpectedly increased in December to 10.9 million. Treasuries were little changed, with the yield on the 10-year note holding steady at 1.79%, on the heels of a 28-basis point (0.28%) increase in January. In commodities, West Texas Intermediate crude hovered at a seven-year high after logging its best month since February 2021 (+17.5%).

In earnings, United Parcel Service Inc. (UPS +14.08%) gapped up for a new all-time high following positive guidance and a boost to its dividend. Elsewhere, Exxon Mobil Corp. (XOM +6.41%) hit a new 52-week high after topping analyst profit estimates and announcing a new $10 billion share repurchase program. In other corporate news, AT&T Inc. (T -4.24%) slid after slashing its dividend by almost 50% and sharing plans to spin off its stake in WarnerMedia after a previously announced combination of the unit with Discovery Inc. (DISCA -2.65%).

Kenneth J. Gruneisen started out as a licensed stockbroker in August 1987, a couple of months prior to the historic stock market crash that took the Dow Jones Industrial Average down -22.6% in a single day. He has published daily fact-based fundamental and technical analysis on high-ranked stocks online for two decades. Through FACTBASEDINVESTING.COM, Kenneth provides educational articles, news, market commentary, and other information regarding proven investment systems that work in good times and bad.

Comments contained in the body of this report are technical opinions only and are not necessarily those of Gruneisen Growth Corp. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. Our firm, employees, and customers may effect transactions, including transactions contrary to any recommendation herein, or have positions in the securities mentioned herein or options with respect thereto. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities.


Financial, Energy, and Biotech Indexes Led Group Gainers

The Bank Index ($BKX +2.37%) and Broker/Dealer Index ($XBD +1.94%) both posted solid gains and the Retail Index ($RLX +0.81%) also edged higher. Energy-linked groups were standout gainers as the Oil Services Index ($OSX +4.23%) and Integrated Oil Index ($XOI +3.04%) both jumped higher. The Gold & Silver Index ($XAU +1.15%) posted a smaller gain. The Biotech Index ($BTK +1.91%) led the tech sector and the Semiconductor Index ($SOX +0.79%) posted a smaller gain, meanwhile, the Networking Index ($NWX -0.13%) ended slightly in the red. 
Chart courtesy of www.stockcharts.com


PICTURED: The Gold & Silver Index ($XAU +1.15%) remains below its 50-day and 200-day moving average (DMA) lines.

Industry Index Symbol Close Change % Change YTD % Change
Oil Services $OSX  67.03 +2.72 +4.23% +27.14%
Integrated Oil $XOI  1,427.83 +42.09 +3.04% +21.19%
Semiconductor $SOX  3,510.86 +27.66 +0.79% -11.03%
Networking $NWX  870.17 -1.14 -0.13% -10.39%
Broker/Dealer $XBD  490.16 +9.31 +1.94% +0.68%
Retail $RLX  3,834.06 +30.98 +0.81% -9.28%
Gold & Silver $XAU  126.46 +1.44 +1.15% -4.53%
Bank $BKX  138.18 +3.20 +2.37% +4.51%
Biotech $BTK  5,174.06 +97.15 +1.91% -6.24%


Earnings News Due While Consolidating Above 200 DMA Line

Regeneron Pharmaceutical (REGN +$4.77 or +0.78% to $613.36) has recently been holding its ground in a tight range above prior lows and above its 200-day moving average (DMA) line ($590.51) which define important near-term support. Keep in mind it is due to report Dec '21 quarterly results on Friday, 2/04/22. Volume and volatility often increase near earnings news. The lack of price progress with higher volume totals in recent weeks is action indicative of distributional pressure. Its Relative Strength rating is 85, still well above the 80+ minimum guideline for buy candidates. A rebound above the 50 DMA line ($629.33) is needed for its outlook to improve. 

REGN was highlighted in yellow with new pivot point cited based on its 9/01/21 high plus 10 cents in the 12/13/21 mid-day report (read here). It was last covered in greater detail on 1/11/22 with an annotated graph under the headline, "Regeneron Still Lingering Below 50-Day Moving Average Line". 

The high-ranked DRUGS - Biotechnology firm reported earnings +84% on +51% sales revenues for the Sep '21 quarter versus the year ago period. That marked its 5th quarterly comparison above the +25% minimum earnings guideline (C criteria) and with a strong sales revenues growth rate. Its annual earnings (A criteria) growth has been strong. It has a 99 Earnings Per Share Rating.

There are 2,733 top-rated funds that own its shares as of Dec '21, up from 2,376 in Dec '20, a reassuring sign concerning the I criteria. Its current Up/Down Volume Ratio of 1.1 is an unbiased indication its shares have been under slight acumulation over the past 50 days. REGN completed a Secondary Offering on 5/28/20. There are 96.2 million shares in the public float (S criteria) which can contribute to greater volatility in the event of institutional buying or selling.

Chart courtesy of www.stockcharts.com

Color Codes Explained :
Y - Better candidates highlighted by our staff of experts.
G - Previously featured in past reports as yellow but may no longer be buyable under the guidelines.

***Last / Change / Volume data in this table is the closing quote data***
Symbol/Exchange
Company Name
Industry Group
PRICE CHANGE
(%Change)
Day High Volume
(% DAV)
(% 50 day avg vol)
52 Wk Hi
% From Hi
Featured
Date
Price
Featured
Pivot Featured
Max Buy
StockCharts.com Latest Chart for REGN REGN - NASDAQ
Regeneron Pharmaceutical
DRUGS - Biotechnology  
$613.36 +4.77
0.78%

$613.93

713,560
94.76% of 50 DAV
50 DAV is 753,000
$686.62
-10.67%
12/13/2021 $647.95 PP = $686.72
MB = $721.06
Most Recent Note - 2/1/2022 4:57:41 PM
G - Recently enduring distributional pressure. A rebound above the 50 DMA line ($629.33) still is needed for its outlook to improve. Due to report Dec '21 quarterly results on Friday, 2/04/22. Volume and volatility often increase near earnings news. Recently holding its ground in a tight range above prior lows and above its 200 DMA line ($590.51) which define the important near-term support. See the latest FSU analysis for more details and a new annotated graph.
>>> FEATURED STOCK ARTICLE : Earnings News Due While Consolidating Above 200 DMA Line - 2/1/2022
 |  View all notes | Set NEW NOTE alert | Company Profile | SEC News | Chart | Request a new note C A  S  I 
StockCharts.com Latest Chart for SF SF - NYSE
Stifel Financial Corp
FINANCIAL SERVICES - Investment Brokerage - Regiona  
$77.76 +2.86
3.82%

$77.91

785,742
150.24% of 50 DAV
50 DAV is 523,000
$78.60
-1.07%
1/27/2022 $74.17 PP = $76.23
MB = $80.04
Most Recent Note - 2/1/2022 5:01:08 PM
Y - Posted a 5th consecutive gain today with +51% above average volume triggering a technical buy signal while rising from a "double bottom" base. Disciplined investors may note Monday's follow-through day in the market (M criteria) confirmed a new uptrend. Bullish action has come since it reported strong results for the Dec '21 quarter versus the year ago period, its 5th strong quarterly comparison. Annual earnings (A criteria) history has been good.
>>> FEATURED STOCK ARTICLE : Formed Double Bottom Base and Faces Little Resistance - 1/27/2022
 |  View all notes | Set NEW NOTE alert | Company Profile | SEC News | Chart | Request a new note C A  S  I 
StockCharts.com Latest Chart for TGH TGH - NYSE
Textainer Group Holdings
TRANSPORTATION - Logistics  
$38.44 +1.66
4.51%

$38.74

443,908
123.65% of 50 DAV
50 DAV is 359,000
$41.24
-6.79%
1/31/2022 $36.68 PP = $41.34
MB = $43.41
Most Recent Note - 2/1/2022 5:03:08 PM
Y - Posted a solid gain today with above average volume. Highlighted in yellow with pivot point cited based on its 11/05/21 high plus 10 cents in the 1/31/22 mid-day report. Consolidating above its 50 DMA line ($35.78) after recently challenging its 52-week high. Subsequent gains above the pivot point backed by at least +40% above average volume are needed to trigger a technical buy signal. Disciplined investors may note a follow-through day in the market (M criteria) confirmed a new uptrend. Found support at its 200 DMA line during its consolidation after dropped from the Featured Stocks list on 11/26/21. Fundamentals remain strong. See the latest FSU analysis for more details and an annotated graph.
>>> FEATURED STOCK ARTICLE : Consolidating Above 50-Day Moving Average - 1/31/2022
 |  View all notes | Set NEW NOTE alert | Company Profile | SEC News | Chart | Request a new note C A  S  I 

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. This site is not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to Premium Membership Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 1-800-965-8307 or 954-785-1121.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us